Characteristics of sudden death in hemodialysis patients

被引:299
作者
Bleyer, A. J. [1 ]
Hartman, J.
Brannon, P. C.
Reeves-Daniel, A.
Satko, S. G.
Russell, G.
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med, Nephrol Sect, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Biostat Sect, Winston Salem, NC 27109 USA
关键词
sudden death; hemodialysis; peritoneal dialysis; cardiovascular; survival;
D O I
10.1038/sj.ki.5000446
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis (HD) is an intermittent procedure during which large fluid and electrolyte shifts occur. We hypothesized that sudden death occurrences in HD patients are related to the timing of HD, and that they occur more frequently in the 12h period starting with dialysis and in the 12 h period at the end of the dialysis-free weekend interval. In a retrospective study, 228 patient deaths were screened to determine if they met the criteria for sudden death. Information was obtained from clinic charts, dialysis center records, and interview of witnesses of the death event. There were 80 HD patients who met the criteria for sudden death. A bimodal distribution of death occurrences was present, with a 1.7-fold increased death risk occurring in the 12 h period starting with the dialysis procedure and a threefold increased risk of death in the 12 h before HD at the end of the weekend interval (P=0.011). Patients with sudden death had a high prevalence of congestive heart failure and coronary artery disease. Only 40% of patients experiencing sudden death were receiving beta-blockers, and the prior monthly serum potassium value was less than 4mEq/l in 25%. Sudden death is temporally related to the HD procedure. Every other day HD could be beneficial in preventing sudden death. Careful attention to the usage of beta-blockers and to the maintenance of normal serum potassium values is indicated in HD patients at risk for sudden death.
引用
收藏
页码:2268 / 2273
页数:6
相关论文
共 34 条
[1]   Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study [J].
Abbott, KC ;
Glanton, CW ;
Trespalacios, FC ;
Oliver, DK ;
Ortiz, MI ;
Agodoa, LY ;
Cruess, DF ;
Kimmel, PL .
KIDNEY INTERNATIONAL, 2004, 65 (02) :597-605
[2]   TREATMENT AND PREVENTION OF HYPERKALEMIA IN END-STAGE RENAL-DISEASE [J].
ALLON, M .
KIDNEY INTERNATIONAL, 1993, 43 (06) :1197-1209
[3]  
ARRIZABALAGA P, 1983, P EUR DIAL TRANS, V20, P572
[4]   Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction [J].
Berger, AK ;
Duval, S ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :201-208
[5]   Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences [J].
Bleyer, AJ ;
Tell, GS ;
Evans, GW ;
Ettinger, WH ;
Burkart, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :72-81
[6]   Sudden and cardiac death rates in hemodialysis patients [J].
Bleyer, AJ ;
Russell, GB ;
Satko, SG .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1553-1559
[7]  
Bleyer AJ, 2001, CARDIAC ELECT PHYSL, V5, P419
[8]   Effects of high-flux Hemodialysis on clinical outcomes: Results of the HEMO study [J].
Cheung, AK ;
Levin, NW ;
Greene, T ;
Agodoa, L ;
Bailey, J ;
Beck, G ;
Clark, W ;
Levey, AS ;
Leypoldt, JK ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, S ;
Teehan, B ;
Eknoyan, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12) :3251-3263
[9]   Dilated cardiomyopathy in dialysis patients - Beneficial effects of carvedilol: A double-blind, placebo-controlled trial [J].
Cice, G ;
Ferrara, L ;
Di Benedetto, A ;
Russo, PE ;
Marinelli, G ;
Pavese, F ;
Iacono, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :407-411
[10]   PARADOXICAL WITHDRAWAL OF REFLEX VASOCONSTRICTION AS A CAUSE OF HEMODIALYSIS-INDUCED HYPOTENSION [J].
CONVERSE, RL ;
JACOBSEN, TN ;
JOST, CMT ;
TOTO, RD ;
GRAYBURN, PA ;
OBREGON, TM ;
FOUADTARAZI, F ;
VICTOR, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1657-1665